| Researcher/Developer |
Vaccine candidate |
Development stage |
| Jilin University |
DNA/MVA |
Phase II |
National Center for AIDS/STD
Control and Prevention, China
CDC |
DNA/TiantanVaccinia |
Phase II |
| Institute of Virology, China CDC |
DNA/MVA (therapeutic) |
Phase I |
Tsinghua University, Hongkong
University, Chinese Academy of
Science |
Modified TiantanVaccinia/
Ad5 |
Pre-clinical |
| Nanjing Medical University |
DNA + gp120 |
Pre-clinical |
Shanghai Pasteur Institute, Chinese
Academy of Science |
DNA /VLP |
Pre-clinica |
|
